New Key Statistics Module, Z-Score and F-Score
NAS:AUTL Key Ratios
| Market Cap $ M | 1,064.14 |
| Enterprise Value $ M | 356.95 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.83 |
| Price/Sales | 85.11 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 10.00 |
| EPS (TTM) $ | -1.21 |
| Beneish M-Score | -2.92 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 16.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.26 |
| EV-to-EBITDA | -2.36 |
| PEG | -- |
| Shares Outstanding M | 266.04 |
| Net Margin (%) | -2,107.86 |
| Operating Margin % | -1,666.66 |
| Pre-tax Margin (%) | -2,070.30 |
| Quick Ratio | 18.29 |
| Current Ratio | 18.29 |
| ROA % (ttm) | -42.65 |
| ROE % (ttm) | -80.74 |
| ROIC % (ttm) | -155.63 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.00 |
AUTL Number of Guru Trades
AUTL Volume of Guru Trades
Gurus Latest Trades with NAS:AUTL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:AUTL is held by these investors
Total 1
Autolus Therapeutics PLC Insider Transactions
No Available Data
News about NAS:AUTL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers